<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen R</submitter><funding>National Key Clinical Specialty Construction Project</funding><pagination>goaf040</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12167634</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13</volume><pubmed_abstract>Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has emerged as a promising therapeutic approach for treating advanced gastric cancer with peritoneal metastases. Herein, we conducted this meta-analysis to evaluate the feasibility, efficacy, and safety of PIPAC in this patient population. The literature between January 2011 and February 2024 was comprehensively searched on the following databases: PubMed, Embase, Web of Science, and the Cochrane Library. The search, guided by the Population-Intervention-Comparison-Outcome (PICO) framework, focused on studies reporting on the feasibility, efficacy, and safety of PIPAC. Data were pooled by using log transformation (PLN) or Freeman-Tukey double arcsine transformation. Of the 451 initially identified studies, 18 were included in the met</pubmed_abstract><journal>Gastroenterology report</journal><pubmed_title>Pressurized intraperitoneal aerosol chemotherapy in advanced gastric cancer with peritoneal metastases: a comprehensive meta-analysis of feasibility, efficacy, and safety.</pubmed_title><pmcid>PMC12167634</pmcid><funding_grant_id>2022YW030009</funding_grant_id><pubmed_authors>Zheng J</pubmed_authors><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Chen R</pubmed_authors><pubmed_authors>Wang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pressurized intraperitoneal aerosol chemotherapy in advanced gastric cancer with peritoneal metastases: a comprehensive meta-analysis of feasibility, efficacy, and safety.</name><description>Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has emerged as a promising therapeutic approach for treating advanced gastric cancer with peritoneal metastases. Herein, we conducted this meta-analysis to evaluate the feasibility, efficacy, and safety of PIPAC in this patient population. The literature between January 2011 and February 2024 was comprehensively searched on the following databases: PubMed, Embase, Web of Science, and the Cochrane Library. The search, guided by the Population-Intervention-Comparison-Outcome (PICO) framework, focused on studies reporting on the feasibility, efficacy, and safety of PIPAC. Data were pooled by using log transformation (PLN) or Freeman-Tukey double arcsine transformation. Of the 451 initially identified studies, 18 were included in the met</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-04-07T20:19:55.606Z</modification><creation>2026-04-07T17:36:13.68Z</creation></dates><accession>S-EPMC12167634</accession><cross_references><pubmed>40520131</pubmed><doi>10.1093/gastro/goaf040</doi></cross_references></HashMap>